Home
NICE Guidance
Published Guidance

Adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis

Technology appraisal guidance [TA130] Published: 22 October 2007

Guidance

This guidance has been updated and replaced by NICE technology appraisal guidance 375.